ALX-0061
ALX0061-C204
Phase 2 mab completed
Quick answer
ALX-0061 for Lupus Erythematosus, Systemic is a Phase 2 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Lupus Erythematosus, Systemic
- Phase
- Phase 2
- Modality
- mab
- Status
- completed